INCRETIN MIMETICS AND THIAZOLIDINEDIONES AS THERAPY AGAINST EXCESSIVE AIRWAY MUCUS TO IMPROVE LUNG FUNCTION IN COPD PATIENTS 3/6/26: MOD P00001 TRANSFER AWARD TO CLEVELAND CLINIC FOUNDATION
$766,910FY2025Defense Health AgencyDOD
The Cleveland Clinic Foundation